- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/25 - Varicella-zoster virus
Patent holdings for IPC class A61K 39/25
Total number of patents in this class: 221
10-year publication summary
|
8
|
9
|
14
|
8
|
11
|
14
|
17
|
24
|
22
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Xiamen University | 534 |
13 |
| Glaxosmithkline Biologicals S.A. | 1653 |
11 |
| Modernatx, Inc. | 1259 |
8 |
| Xiamen Innovax Biotech Co., Ltd. | 90 |
7 |
| Northwestern University | 3401 |
6 |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | 27 |
6 |
| Mogam Institute for Biomedical Research | 71 |
6 |
| Board of Regents of the University of Nebraska | 761 |
5 |
| Institute for Research in Biomedicine | 100 |
4 |
| Rutgers, The State University of New Jersey | 1896 |
4 |
| Curevo, Inc. | 7 |
4 |
| Merck Sharp & Dohme Corp. | 2191 |
3 |
| Merck Patent GmbH | 5812 |
3 |
| Adjuvance Technologies, Inc., AKA Adjuvance | 22 |
3 |
| Celltrion, Inc. | 337 |
3 |
| Dynavax Technologies Corporation | 117 |
3 |
| Eyegene, Inc. | 34 |
3 |
| Icahn School of Medicine at Mount Sinai | 955 |
3 |
| Oxford University Innovation Limited | 1541 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2858 |
3 |
| Other owners | 120 |